<?xml version="1.0" encoding="UTF-8" standalone="yes"?><ns0:RetrieveMultipleValueSetsResponse xmlns:ns0="urn:ihe:iti:svs:2008" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">    <ns0:DescribedValueSet ID="2.16.840.1.113883.3.117.1.7.1.134" displayName="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" version="N/A">        <ns0:ConceptList>            <ns0:Concept code="1114198" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="rivaroxaban 10 MG Oral Tablet"/>            <ns0:Concept code="1232082" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="rivaroxaban 15 MG Oral Tablet"/>            <ns0:Concept code="1232086" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="rivaroxaban 20 MG Oral Tablet"/>            <ns0:Concept code="1364435" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="apixaban 2.5 MG Oral Tablet"/>            <ns0:Concept code="1364445" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="apixaban 5 MG Oral Tablet"/>            <ns0:Concept code="1549682" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="{42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack"/>            <ns0:Concept code="1599543" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="edoxaban 15 MG Oral Tablet"/>            <ns0:Concept code="1599551" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="edoxaban 30 MG Oral Tablet"/>            <ns0:Concept code="1599555" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="edoxaban 60 MG Oral Tablet"/>            <ns0:Concept code="1927856" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="betrixaban 40 MG Oral Capsule"/>            <ns0:Concept code="1927864" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="betrixaban 80 MG Oral Capsule"/>            <ns0:Concept code="1992427" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="{74 (apixaban 5 MG Oral Tablet) } Pack"/>            <ns0:Concept code="2059015" codeSystem="2.16.840.1.113883.6.88" codeSystemName="RXNORM" codeSystemVersion="2019-10" displayName="rivaroxaban 2.5 MG Oral Tablet"/>        </ns0:ConceptList>        <ns0:Source>The Joint Commission</ns0:Source>        <ns0:Purpose>(Clinical Focus: This value set contains concepts that represent oral factor Xa inhibitors indicated for venous thromboembolism (VTE) prophylaxis and treatment. ),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive oral factor Xa inhibitors for VTE prophylaxis. ),(Inclusion Criteria: Includes only relevant concepts associated with oral forms of factor Xa inhibitors.),(Exclusion Criteria: Excludes other dose forms of factor Xa inhibitors.)</ns0:Purpose>        <ns0:Type>Extensional</ns0:Type>        <ns0:Binding>Dynamic</ns0:Binding>        <ns0:Status>Active</ns0:Status>        <ns0:RevisionDate>2019-03-05</ns0:RevisionDate>    </ns0:DescribedValueSet></ns0:RetrieveMultipleValueSetsResponse>